CORONAVIRUS/COVID-19-induced thromboinflammation linked to CLEC2: NHRI
07/17/2023 06:49 PM
A new study by Taiwan's National Health Research Institute (NHRI) has identified a link between CLEC2, a C-type lectin-like type II transmembrane receptor, and thromboinflammation, the major cause of morbidity and mortality in COVID-19 patients.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
More in CORONAVIRUS
- COVID-19 epidemic phase to pass mid-August: CDCAlthough Taiwan is still in a COVID-19 epidemic phase, it is expected to pass by mid-August, said the Centers for Disease Control (CDC) at a press conference in Taipei on Tuesday.07/30/2024 08:01 PM
- COVID-19, influenza outbreaks have peaked: CDCCOVID-19 and influenza cases in Taiwan have peaked, with the epidemic phases likely to pass by mid-August, the Centers for Disease Control (CDC) said Tuesday.07/16/2024 08:45 PM
- CDC to buy 5.5 million Moderna JN.1 COVID-19 vaccine shots for October rolloutThe Centers for Disease Control (CDC) on Wednesday announced a plan to purchase 5.5 million doses of the Moderna monovalent JN.1 COVID-19 vaccine, which will be administered, along with the flu vaccine, from Oct. 1.07/10/2024 09:40 PM
Latest
- Sports
- Politics
IC cooperation with Lithuania continues despite factory construction halt
11/16/2024 02:53 PM - Society
Usagi downgraded to tropical depression, warnings lifted
11/16/2024 01:05 PM - Politics
Taiwan's APEC envoy chats with Biden, extends invitation for visit
11/16/2024 12:25 PM - Politics
Legislators pass amendment to effectively remove NCC acting head
11/16/2024 11:30 AM